TOT BIOPHARM International Co. Ltd.(HK:1875)
HK$3.47+0.08 (+2.36%)
HK:1875
TOT BIOPHARM International Co. Ltd. financials statements
HK$3.47
At close:+0.08 (+2.36%)
Want to see HK:1875 full AI Analyst Report?
TOT BIOPHARM International Co. Ltd. (1875) Income Statement
0 Followers
TOT BIOPHARM International Co. Ltd. Income Statement
Last quarter (Q2 2026), TOT BIOPHARM International Co. Ltd.'s total revenue was ¥242.62M, a decrease of 53.40% from the same quarter last year. In Q2, TOT BIOPHARM International Co. Ltd.'s net income was ¥-57.71M. See TOT BIOPHARM International Co. Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| ¥ 747.64M | ¥ 1.10B | ¥ 780.63M | ¥ 442.18M | ¥ 76.33M | |
| ¥ 388.98M | ¥ 782.43M | ¥ 573.99M | ¥ 370.62M | ¥ 27.47M | |
| ¥ 479.67M | ¥ 741.18M | ¥ 607.05M | ¥ 409.45M | ¥ 287.17M | |
| Depreciation and Amortization | ¥ 79.20M | ¥ 65.42M | ¥ 43.03M | ¥ 38.04M | ¥ 34.24M |
| ¥ -1.29M | ¥ 111.58M | ¥ 10.45M | ¥ -5.41M | ¥ -224.51M | |
| ¥ -90.69M | ¥ 41.25M | ¥ -33.06M | ¥ -39.08M | ¥ -259.70M | |
| ¥ -9.68M | ¥ -6.50M | ¥ -4.70M | ¥ -10.97M | ¥ -1.52M | |
| ¥ -100.37M | ¥ 34.76M | ¥ -37.76M | ¥ -50.05M | ¥ -261.22M | |
| ¥ -100.37M | ¥ 34.76M | ¥ -37.76M | ¥ -49.92M | ¥ -261.22M | |
| Per Share Metrics | |||||
| Basic EPS | ¥ -0.14 | ¥ 0.05 | ¥ -0.05 | ¥ -0.08 | ¥ -0.46 |
| Diluted EPS | ¥ -0.14 | ¥ 0.05 | ¥ -0.05 | ¥ -0.08 | ¥ -0.46 |
| Weighted Average Shares Outstanding | 725.20M | 725.20M | 725.20M | 639.31M | 573.36M |
| Weighted Average Shares Outstanding (Diluted) | 725.20M | 725.20M | 725.20M | 639.31M | 573.36M |
Currency in CNY

